Herpes
Studies from Sweden, Australia and the United States advance knowledge in herpes research
Published in Women's Health Weekly, September 7th, 2006
Study 1: Mucosal administration of CpG oligodeoxynucleotide (ODN) elicits strong CC and CXC chemokine responses in the vagina and serves as a potent Th1-tilting adjuvant for recombinant gD2 protein vaccination against genital herpes.
Scientists in Sweden and the United States report, "Although sexually transmitted pathogens are capable of inducing pathogen-specific immune responses, vaginal administration of nonreplicating antigens elicits only weak, nondisseminating immune responses. The present study was undertaken to examine the potential of CpG-containing...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Breast Cancer
Ki-67 expression found in breast fluid may be biomarker for early cancer detection - Irritable Bowel Syndrome
Gender influences sensitivity to rectosigmoid distension in irritable bowel syndrome - Stroke
Healthy behaviors decrease risk of ischemic stroke in women - Type 2 Diabetes
Dairy intake may lower risk of type 2 diabetes in older to middle-aged minority women - Type 2 Diabetes
Ethnicity plays major role in women as risk factor for developing type 2 diabetes - Assisted Reproduction
Fertility preservation is possible after surgery/chemotherapy for malignant germ cell tumors - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
